Sapient Capital LLC Acquires New Position in AbbVie Inc. (NYSE:ABBV)

Sapient Capital LLC bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 323,332 shares of the company’s stock, valued at approximately $50,107,000. AbbVie comprises about 1.3% of […]

Related Keywords

Raymond James ,Venclexta Venclyxto ,Richarda Gonzalez ,William Blair ,Azita Saleki Gerhardt ,Abbvie Company Profile ,Blue Bell Private Wealth Management ,Horrell Capital Management Inc ,Dinuzzo Private Wealth Inc ,Exchange Commission ,Sapient Capital ,Securities Exchange Commission ,Bourgeon Capital Management ,Core Wealth Advisors Inc ,Abbvie Inc ,Free Report ,Bell Private Wealth Management ,Nuzzo Private Wealth ,Capital Management ,Wealth Advisors ,Get Free Report ,Vie Inc ,Abbvie Daily ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,